Beta Glucan Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Beta Glucan Market size was valued at USD 421.6 million in 2023 and is expected to grow at 7.2% CAGR from 2024 to 2032. As chronic health issues like diabetes, high cholesterol, heart disease, and obesity become more prevalent, the demand for health and wellness products is surging, potentially fueling market growth.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Beta Glucan Market Size in 2023: | USD 421.6 Million |
Forecast Period: | 2024–2032 |
Forecast Period 2023 - 2032 CAGR: | 7.2 |
2023 Value Projection: | USD 777.8 Million |
Historical Data for: | 2021–2023 |
No of Pages: | 200 |
Tables, Charts & Figures: | 211 |
Segments Covered: | By Extract and By Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Additionally, Market is driven by heightened consumer awareness of health benefits and a surge in demand for functional foods and dietary supplements, the global beta-glucan market is experiencing robust growth. Renowned for their immune-boosting and cholesterol-lowering properties, beta-glucans are gaining traction in diverse sectors, including pharmaceuticals, nutraceuticals, and food & beverages. The market's momentum is further fueled by the rising prevalence of chronic diseases and an aging population, both of which are steering a shift towards preventive healthcare.
Technological advancements in extraction and formulation are also playing a pivotal role in this market expansion. Moreover, the ascent of e-commerce platforms is broadening consumer access to beta-glucan products. Key players are not only innovating but also forging strategic partnerships to seize emerging opportunities. Nevertheless, the beta-glucan market's growth trajectory could be impeded by regulatory challenges and the significant investments required for research and development.
Advanced food processing techniques, including assisted ultrasound, enzyme extraction, and pressurized extraction, offer a promising platform for extracting beta-glucan from sources like wheat and barley cereals, seaweed strains, and mushrooms. However, these methods are time-consuming and come with high instrumentation costs. Furthermore, while beneficial, high doses of the product can lead to side effects, including allergic reactions, diarrhea, excessive gas, nausea, and abdominal bloating.
Asia Pacific sees a surge in mushroom cultivation, driving up the supply of beta-glucan due to its abundant presence in mushrooms. In North America, the demand for processed foods with heightened nutritional value is on the rise, fueling market growth as beta-glucans gain traction for their health benefits. Europe's market is expanding, driven by an increasing emphasis on health and wellness products, with beta-glucans being integrated for their functional properties. Meanwhile, in LATAM, the burgeoning food and beverage industry is sparking interest in beta-glucans, as manufacturers aim to enhance their products with health-promoting ingredients.
Technological advancements are propelling significant growth and innovation in the global beta-glucan industry. Noteworthy trends encompass the emergence of novel extraction methods, including enzymatic and fermentation-based techniques. These methods not only boost yield and purity but also curtail costs. Additionally, breakthroughs in nanotechnology are amplifying the bioavailability and efficacy of beta-glucans, particularly in functional foods and pharmaceuticals.
Biotechnology is further refining beta-glucan production, tailoring properties for distinct health benefits, be it enhanced immune modulation or superior gut health. The infusion of AI and machine learning into research is hastening the identification of new applications and streamlining production processes. Such technological strides are broadening the horizons for beta-glucan applications, fueling market growth in sectors like nutraceuticals, cosmetics, and medical supplements. Consequently, with enriched product offerings and heightened consumer awareness of health benefits, the market is set for vigorous expansion.
The market is segmented by extracting cereal grains, yeast, mushroom and seaweed. Cereal grains are further sub-divided by products into oats and barley. The cereal grains segment will capture USD 278.9 million and demonstrate a 6.9% CAGR through 2032.
Oats are known for their ability to lower blood cholesterol and sugar levels, as well as prevent cardiovascular issues. This is projected to drive the demand for cereal grains in the coming years. Daily consumption of just 3 grams of oat beta-glucan can lead to a 10% reduction in LDL cholesterol and a 20% decrease in the risk of cardiovascular disease.
Barley, another cereal grain, is recognized for its benefits, including blood pressure maintenance, cholesterol control, and immune system stimulation. These attributes are likely to boost the demand for barley. Furthermore, major industry players are intensifying efforts to source high-quality barley and develop advanced extraction technologies. This focus on quality could further accelerate the growth of the market.
The North America beta glucan market is projected to achieve USD 255.3 million, with a CAGR of 7% from 2024 to 2032. Technological advancements are reshaping the market in North America. Noteworthy trends encompass the evolution of sophisticated extraction and purification technologies, which bolster the quality and bioavailability of beta-glucans. Techniques like enzymatic hydrolysis and advanced filtration are streamlining beta-glucan production, yielding superior purity and potency. Furthermore, biotechnology is pioneering the development of beta-glucans with customized properties, targeting specific health benefits such as boosted immune support and enhanced gut health.
Moreover, the infusion of AI and machine learning into research is hastening the discovery of novel applications and refining production methods. These tech strides resonate with the surging consumer appetite for health-centric, nutritionally enriched processed foods. Consequently, buoyed by these technological breakthroughs, the North American market is witnessing vigorous growth, particularly in sectors like functional foods, dietary supplements, and nutraceuticals.
Companies include, Cargill, Kerry Group, DSM, Lesaffre International, and Angel Yeast Co., Ltd. are spearheading significant advancements. Cargill harnesses its vast research capabilities and global distribution network to supply high-quality beta-glucans for diverse applications, spanning nutraceuticals to functional foods. Kerry Group is integrating beta-glucans into its health-centric product lines, thereby boosting their nutritional value. DSM distinguishes itself with innovative extraction and formulation techniques, primarily serving the pharmaceutical and dietary supplement industries.
Lesaffre International, leveraging its fermentation technology expertise, crafts beta-glucans with specific health benefits. Meanwhile, Angel Yeast Co., Ltd., celebrated for its premium yeast products, offers high-purity beta-glucans suited for the food and beverage sector. Together, these companies are not only enhancing product quality and broadening applications but also addressing the surging consumer demand for health-promoting ingredients.
Top companies operating in the beta glucan industry include:
Market, By Extract
The above information is provided for the following regions and countries:
Top companies leading the market include Cargill, Kerry Group, DSM, Lesaffre International, and Angel Yeast Co., Ltd. These companies are driving advancements in extraction technologies and expanding the application of beta-glucans in diverse sectors.
North America is expected to dominate the market by 2032, achieving USD 255.3 million with a CAGR of 7.0%. The region's market growth is propelled by technological advancements in extraction methods and the rising demand for nutritionally enriched processed foods.
The market size of beta-glucan reached USD 421.6 million and is set to grow at 7.2% CAGR from 2024 to 2032, led by the rising prevalence of chronic health issues and increasing consumer demand for health-focused dietary products.
The cereal grains segment, particularly oats and barley, is expected to lead the beta-glucan market by 2032, capturing USD 278.9 million and demonstrating a 6.9% CAGR due to their cholesterol-lowering, heart disease-preventing, and immune-boosting properties.